Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Active Transdermal Drug Delivery Device market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Active Transdermal Drug Delivery Device market. Detailed analysis of key players, along with key growth strategies adopted by Active Transdermal Drug Delivery Device industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
3M
Corium International, Inc
Bayer AG
Mylan NV
Actavis, Inc
Noven Pharmaceuticals, Inc
GlaxoSmithKline plc
Echo Therapeutics, Inc
Novartis AG
Boehringer Ingelheim GmbH
Johnson & Johnson (Janssen Pharmaceuticals Inc)
Transdermal Corp
By Type:
Patches
Gels
By End-User:
Clinic
Hospital
Home Use
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Active Transdermal Drug Delivery Device Market
-
1.3 Market Segment by Type
-
1.3.1 China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Patches from 2016 to 2027
-
1.3.2 China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Gels from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.2 China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Home Use from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Active Transdermal Drug Delivery Device Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Active Transdermal Drug Delivery Device by Major Types
-
3.4.1 Market Size and Growth Rate of Patches
-
3.4.2 Market Size and Growth Rate of Gels
4 Segmentation of Active Transdermal Drug Delivery Device Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Active Transdermal Drug Delivery Device by Major End-Users
-
4.4.1 Market Size and Growth Rate of Active Transdermal Drug Delivery Device in Clinic
-
4.4.2 Market Size and Growth Rate of Active Transdermal Drug Delivery Device in Hospital
-
4.4.3 Market Size and Growth Rate of Active Transdermal Drug Delivery Device in Home Use
5 Market Analysis by Regions
-
5.1 China Active Transdermal Drug Delivery Device Production Analysis by Regions
-
5.2 China Active Transdermal Drug Delivery Device Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Active Transdermal Drug Delivery Device Landscape Analysis
-
6.1 North China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
6.2 North China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
7 Central China Active Transdermal Drug Delivery Device Landscape Analysis
-
7.1 Central China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
7.2 Central China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
8 South China Active Transdermal Drug Delivery Device Landscape Analysis
-
8.1 South China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
8.2 South China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
9 East China Active Transdermal Drug Delivery Device Landscape Analysis
-
9.1 East China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
9.2 East China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
10 Northeast China Active Transdermal Drug Delivery Device Landscape Analysis
-
10.1 Northeast China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
10.2 Northeast China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
11 Southwest China Active Transdermal Drug Delivery Device Landscape Analysis
-
11.1 Southwest China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
11.2 Southwest China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
12 Northwest China Active Transdermal Drug Delivery Device Landscape Analysis
-
12.1 Northwest China Active Transdermal Drug Delivery Device Landscape Analysis by Major Types
-
12.2 Northwest China Active Transdermal Drug Delivery Device Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 3M
-
13.1.1 3M Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Corium International, Inc
-
13.2.1 Corium International, Inc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Bayer AG
-
13.3.1 Bayer AG Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Mylan NV
-
13.4.1 Mylan NV Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Actavis, Inc
-
13.5.1 Actavis, Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Noven Pharmaceuticals, Inc
-
13.6.1 Noven Pharmaceuticals, Inc Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 GlaxoSmithKline plc
-
13.7.1 GlaxoSmithKline plc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Echo Therapeutics, Inc
-
13.8.1 Echo Therapeutics, Inc Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Novartis AG
-
13.9.1 Novartis AG Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Boehringer Ingelheim GmbH
-
13.10.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
13.11.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Transdermal Corp
-
13.12.1 Transdermal Corp Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Patches from 2016 to 2027
-
Figure China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Gels from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Active Transdermal Drug Delivery Device Market Size and Growth Rate of Home Use from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Active Transdermal Drug Delivery Device Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Active Transdermal Drug Delivery Device
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Active Transdermal Drug Delivery Device by Different Types from 2016 to 2027
-
Table Consumption Share of Active Transdermal Drug Delivery Device by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Patches
-
Figure Market Size and Growth Rate of Gels
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Active Transdermal Drug Delivery Device by Different End-Users from 2016 to 2027
-
Table Consumption Share of Active Transdermal Drug Delivery Device by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Home Use
-
Table China Active Transdermal Drug Delivery Device Production by Regions
-
Table China Active Transdermal Drug Delivery Device Production Share by Regions
-
Figure China Active Transdermal Drug Delivery Device Production Share by Regions in 2016
-
Figure China Active Transdermal Drug Delivery Device Production Share by Regions in 2021
-
Figure China Active Transdermal Drug Delivery Device Production Share by Regions in 2027
-
Table China Active Transdermal Drug Delivery Device Consumption by Regions
-
Table China Active Transdermal Drug Delivery Device Consumption Share by Regions
-
Figure China Active Transdermal Drug Delivery Device Consumption Share by Regions in 2016
-
Figure China Active Transdermal Drug Delivery Device Consumption Share by Regions in 2021
-
Figure China Active Transdermal Drug Delivery Device Consumption Share by Regions in 2027
-
Table North China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table North China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table North China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table North China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure North China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table Central China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table Central China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table Central China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table Central China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure Central China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table South China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table South China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table South China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table South China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure South China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table East China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table East China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table East China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table East China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure East China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table Northeast China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table Northeast China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table Northeast China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table Northeast China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure Northeast China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table Southwest China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table Southwest China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table Southwest China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table Southwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure Southwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table Northwest China Active Transdermal Drug Delivery Device Consumption by Types from 2016 to 2027
-
Table Northwest China Active Transdermal Drug Delivery Device Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2016
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2021
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by Types in 2027
-
Table Northwest China Active Transdermal Drug Delivery Device Consumption by End-Users from 2016 to 2027
-
Table Northwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2016
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2021
-
Figure Northwest China Active Transdermal Drug Delivery Device Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of 3M
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3M
-
Figure Sales and Growth Rate Analysis of 3M
-
Figure Revenue and Market Share Analysis of 3M
-
Table Product and Service Introduction of 3M
-
Table Company Profile and Development Status of Corium International, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Corium International, Inc
-
Figure Sales and Growth Rate Analysis of Corium International, Inc
-
Figure Revenue and Market Share Analysis of Corium International, Inc
-
Table Product and Service Introduction of Corium International, Inc
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Mylan NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV
-
Figure Sales and Growth Rate Analysis of Mylan NV
-
Figure Revenue and Market Share Analysis of Mylan NV
-
Table Product and Service Introduction of Mylan NV
-
Table Company Profile and Development Status of Actavis, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis, Inc
-
Figure Sales and Growth Rate Analysis of Actavis, Inc
-
Figure Revenue and Market Share Analysis of Actavis, Inc
-
Table Product and Service Introduction of Actavis, Inc
-
Table Company Profile and Development Status of Noven Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noven Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Noven Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Noven Pharmaceuticals, Inc
-
Table Product and Service Introduction of Noven Pharmaceuticals, Inc
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Echo Therapeutics, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Echo Therapeutics, Inc
-
Figure Sales and Growth Rate Analysis of Echo Therapeutics, Inc
-
Figure Revenue and Market Share Analysis of Echo Therapeutics, Inc
-
Table Product and Service Introduction of Echo Therapeutics, Inc
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
Table Company Profile and Development Status of Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
Figure Revenue and Market Share Analysis of Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
Table Product and Service Introduction of Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
Table Company Profile and Development Status of Transdermal Corp
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transdermal Corp
-
Figure Sales and Growth Rate Analysis of Transdermal Corp
-
Figure Revenue and Market Share Analysis of Transdermal Corp
-
Table Product and Service Introduction of Transdermal Corp
-
